No abstract available
MeSH terms
-
Algorithms
-
Anticoagulants / therapeutic use
-
Biomarkers
-
Cost-Benefit Analysis
-
Diagnostic Tests, Routine
-
Disease Management
-
Drug Monitoring
-
Evidence-Based Medicine
-
Fibrin Fibrinogen Degradation Products / analysis
-
Humans
-
Liver Function Tests
-
National Institutes of Health (U.S.)
-
Practice Guidelines as Topic*
-
Pulmonary Embolism / diagnosis
-
Symptom Assessment
-
Thrombophilia / complications
-
Thrombophilia / diagnosis
-
United States
-
Unnecessary Procedures
-
Venous Thromboembolism* / diagnosis
-
Venous Thromboembolism* / drug therapy
-
Venous Thromboembolism* / economics
-
Venous Thromboembolism* / etiology
Substances
-
Anticoagulants
-
Biomarkers
-
Fibrin Fibrinogen Degradation Products
-
fibrin fragment D